期刊文献+

伴上皮成分恶变的乳腺叶状肿瘤5例临床病理分析 被引量:2

Phyllode tumors of the breast with malignant epithelial component: a clinicopathological analysis of five cases
原文传递
导出
摘要 目的探讨伴有上皮成分恶变的乳腺叶状肿瘤(PTs)临床病理学特征,提高对该病的诊治水平。方法报道5例伴有上皮成分恶变的乳腺PTs,采用SMA、vimentin、CD34、bcl-2、Ki-67、ER、PR、CK5、p63、E-cadherin和p120等抗体进行免疫组化染色,并复习文献。结果 5例伴上皮成分恶变的PTs均为女性,年龄26~58岁(中位年龄53岁),均以原有肿物短期内迅速增大而手术治疗。镜下表现为纤维上皮性肿瘤,上皮成分恶变为低级别导管原位癌(DCIS)3例,低级别导管原位癌及小叶原位癌(DCIS和LCIS)1例,小叶原位癌及浸润性小叶癌(LCIS和ILC)1例;间质成分为良性PTs 2例,交界性PTs 3例。免疫组化示恶变的上皮成分弥漫ER、PR(+),DCIS显示Ecadherin、p120膜(+),CK5(-);LCIS显示p120浆(+),E-cadherin(-)。PTs间质成分SMA和CD34均(+),2例bcl-2(+)。随访4~72个月,均未见复发及转移。结论伴上皮成分恶变的乳腺PTs罕见,癌的免疫组化表达与普通型乳腺癌一样,但PTs内癌的预后稍好,目前尚无标准治疗方案。 Objective To investigate the clinicopathological features of the carcinoma arising in phyllode tumors of the breast. Methods Morphological observation and immunohistochemistry using Envision method were performed on 5 cases of carcinoma arising in phyllodes tumors of the breast from January 2000 to may 2017. Results All 5 patients were female,aged 26 ~ 58 years(median age 53),and all the masses increased rapidly in short time. 2 cases arose from benign phyllode tumors including DCIS,LCIS and ILC; 3 DCIS arose from borderline phyllode tumors. Immunohistochemistry showed all malignant epithelial components were diffusely positive for ER and PR,and DCIS was positive for p120 and Ecadherin,LCIS was positive for p120 and negative for E-cadherin; mesenchymal component all expressed CD34 and 2 cases were also Bcl-2 positive. All patients were alive without recurrence and metastasis followed by 4 ~ 72 months.Conclusion Carcinoma arising from phyllode tumors of the breast is rare and characterized by in situ and invasive carcinoma in a background of phyllode tumor of the breast. The immunohistochemical features of malignant epithelial component are similar to ordinary breast cancer,but with better prognosis. Because of its rarity,there is no standardized treatment prescription for this disease.
作者 崔力方 张继新 昌红 赵宏禹 李曌 曲从玲 钟定荣 CUI Li-fang;ZHANG Ji-xin;CHANG Hong;ZHAO Hong-yu;LI Zhao;Qu Li-ling;ZHONG Ding-rong(Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100028, China;Department of Pathology, Peking University First Hospital, Beijin9 100034, China;Department of Pathology, Peking Union Medical Hospital, Chinese Academy of Medical Science, Beijing 100730, China)
出处 《诊断病理学杂志》 2018年第1期12-16,共5页 Chinese Journal of Diagnostic Pathology
关键词 乳腺癌 叶状肿瘤 恶变 Breast cancer Phyllode tumor Malignant transformation
  • 相关文献

参考文献3

二级参考文献41

  • 1Tavassoli FA,Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs[M]. Lyon:IARC,2003:40-1.
  • 2Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast Ⅲ carcinosarcoma[J]. Cancer,1989,64(7):1490-9.
  • 3付斌燕 余英豪.乳腺癌肉瘤1例报告[J].实用癌症杂志,2000,15(3):283-283.
  • 4李洪爱 祁正茂 石群立.乳腺癌肉瘤1例[J].解放军医学杂志,1995,20(2):151-151.
  • 5Gogas J, Kouskos E, Markopoulos C, et al. Carcinosarcoma of the breast: report of two cases[J]. Eur J Gynaecol Oncol,2003,24(1):93-5.
  • 6Teixeira MR, Qvist H, Bohler PJ, et al. Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin[J]. Genes Chromosomes Cancer, 1998,22(2):145-51.
  • 7Wada H, Enomoto T, Tsujimoto M, et al. Carcinosarcoma of the breast: molecular-biological study for analysis of histogenesis[J]. Hum Pathol,1998,29(11):1324-8.
  • 8Kurian KM, Al-Nafussi A. Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases[J]. Histopathology, 2002,40(1):58-64.
  • 9Brenner RJ, Turner RR, Schiller V, et al. Metaplastic carcinoma of the breast: report of three cases[J]. Cancer,1998,82(6):1082-7.
  • 10Wang X, Mori I, Tang W, et al. Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components[J]. Mod Pathol, 2001,14(11):1183-6.

共引文献19

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部